In the above studies in PPMS and RMS, GA Depot showed EDSS stabilization, irrespective of baseline EDSS scores. These EDSS findings suggest GA Depot's potential in slowing disability progression, ...

Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable treatments, will present efficacy data ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

"We make that," Fields told him with infectious pride. Not literally, of course. The "Darkstar" scramjet that gets ripped apart at Mach-10 is a fictional aircraft, flying at a currently impossible ...

ATI Inc. delivered solid margin expansion and double-digit EPS growth in Q4 despite muted topline growth, thanks to strong pricing and mix. Robust jet engine and commercial aerospace demand should ...

ATI (ATI) is rated Hold, reflecting high 2026 growth but tempered by sector cyclicality and normalization risks. Consensus expects 48% EPS growth in 2026, driven by aerospace demand. ATI’s margins and ...

STOCKEY. HERE’S WHAT’S HAPPENING AND WHAT WE’RE WORKING ON. BEGIN WITH YOUR TOP FOUR STORIES AT 4:00. AND WE’RE TRACKING AN INVESTIGATION AT A CHEMICAL PLANT IN WESTMORELAND COUNTY. WE’RE BEING TOLD ...

A 21-year-old woman died in Navi Mumbai after allegedly receiving injections from a ward boy who posed as a doctor, police said on Monday. The incident occurred on February 5 in Vashi area of Navi ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

(MENAFN- GlobeNewsWire - Nasdaq) NESS ZIONA, Israel, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on ...

NESS ZIONA, Israel, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting ...